XM does not provide services to residents of the United States of America.
H
H

HowdenJoinery

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

UK corporate earnings week ahead

DIARY-UK corporate earnings week ahead July 19 (Reuters) - Diary of U.K (.FTSE) corporate earnings for the week ahead UK EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 24-Jul-2024 NTS UTG.L Unite Group PLC Half Year 2024 Unite Group PLC Earnings Release 24-Jul-2024 BMO INF.L Informa PLC Half Year 2024 Informa PLC Earnings Release 24-Jul-2024 06:00 EZJ.L Easyjet PLC Q3 2024 Easyjet PLC Earnings Release 24-Jul-2024 06:00 RKT.L Reckitt Benckiser Group PLC Half Year 2024 Reckitt Be
A
C
E
H
I
L
R
R
R
S
U

UK housebuilding stocks lifted by Labour election win

UPDATE 3-UK housebuilding stocks lifted by Labour election win UK homebuilders top gainers in FTSE 100 Other housing stocks also climb Updates share moves in paragraphs 5, 6 and 8, adds HBF response in paragraphs 9-10, analyst comment in paragraph 11 By Aby Jose Koilparambil and Yadarisa Shabong July 5 (Reuters) - British housebuilding companies were the top gainers on the FTSE 100 .FTSE on Friday as investors welcomed the election victory by the Labour Party, which said it wanted 1.5 million ne
B
H
P
T
T
U

Credit Agricole, Hermes, Whitbread

EUROPE RESEARCH ROUNDUP-Credit Agricole, Hermes, Whitbread June 12 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Credit Agricole, Hermes and Whitbread, on Wednesday. HIGHLIGHTS * Credit Agricole CAGR.PA : Jefferies raises to buy from hold * Flutter Entertainment Plc FLTRF.L : JP Morgan cuts target price to 20,700p from 21,300p * Hermes HRMS.PA : Barclays cuts target price to EUR 2320 from EUR 2410 * Renew Holdings Plc RNWH.L : Ber
A
A
A
A
B
B
C
G
H
H
H
H
H
I
M
R
R
R
S
S
U
W
A
F
S
S
Z

4Imprint, AstraZeneca, Bellway

EUROPE RESEARCH ROUNDUP-4Imprint, AstraZeneca, Bellway June 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including 4Imprint, AstraZeneca and Bellway, on Wednesday. HIGHLIGHTS * 4Imprint FOUR.L : HSBC raises target price to 6370p from 6060p * AstraZeneca AZN.L : HSBC raises target price to 14070p from 12950p * Bellway Plc BWY.L : Berenberg raises target price to 2900p from 2500p * Berkeley Group BKGH.L : Berenberg raises target price to
A
A
B
B
B
B
B
C
E
G
G
H
H
I
M
M
O
P
R
R
S
B
E
M
N
P
R
S
T

Howden Joinery Says Roisin Currie, Suzy Neubert To Be Appointed Independent Non-Exec Directors

BRIEF-Howden Joinery Says Roisin Currie, Suzy Neubert To Be Appointed Independent Non-Exec Directors May 7 (Reuters) - Howden Joinery Group PLC HWDN.L : HOWDEN JOINERY - ROISIN CURRIE AND SUZY NEUBERT WILL BE APPOINTED AS INDEPENDENT NON-EXECUTIVE DIRECTORS Source text for Eikon: ID:nRSG4664Na Further company coverage: HWDN.L
H

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.